搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodospirillum rubrum Elongation factor Tu 1 (tuf1) CSB-YP646995RMB
CSB-EP646995RMB
CSB-BP646995RMB
CSB-MP646995RMB
CSB-EP646995RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 50S ribosomal protein L16 (rplP) CSB-YP646996RMB
CSB-EP646996RMB
CSB-BP646996RMB
CSB-MP646996RMB
CSB-EP646996RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 30S ribosomal protein S8 (rpsH) CSB-YP646997RMB
CSB-EP646997RMB
CSB-BP646997RMB
CSB-MP646997RMB
CSB-EP646997RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 50S ribosomal protein L17 (rplQ) CSB-YP646998RMB
CSB-EP646998RMB
CSB-BP646998RMB
CSB-MP646998RMB
CSB-EP646998RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 1,4-alpha-glucan branching enzyme GlgB (glgB), partial CSB-YP646999RMB
CSB-EP646999RMB
CSB-BP646999RMB
CSB-MP646999RMB
CSB-EP646999RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Peptide methionine sulfoxide reductase MsrA (msrA) CSB-YP647000RMB
CSB-EP647000RMB
CSB-BP647000RMB
CSB-MP647000RMB
CSB-EP647000RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB) CSB-YP647001RMB
CSB-EP647001RMB
CSB-BP647001RMB
CSB-MP647001RMB
CSB-EP647001RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Aspartate--tRNA ligase (aspS), partial CSB-YP647002RMB
CSB-EP647002RMB
CSB-BP647002RMB
CSB-MP647002RMB
CSB-EP647002RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 2-isopropylmalate synthase (leuA), partial CSB-YP647003RMB
CSB-EP647003RMB
CSB-BP647003RMB
CSB-MP647003RMB
CSB-EP647003RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP647004RMB
CSB-EP647004RMB
CSB-BP647004RMB
CSB-MP647004RMB
CSB-EP647004RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum N utilization substance protein B homolog (nusB) CSB-YP647005RMB
CSB-EP647005RMB
CSB-BP647005RMB
CSB-MP647005RMB
CSB-EP647005RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 5'-nucleotidase surE (surE) CSB-YP647006RMB
CSB-EP647006RMB
CSB-BP647006RMB
CSB-MP647006RMB
CSB-EP647006RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Phosphate acyltransferase (plsX) CSB-YP647007RMB
CSB-EP647007RMB
CSB-BP647007RMB
CSB-MP647007RMB
CSB-EP647007RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Proline--tRNA ligase (proS) CSB-YP647008RMB
CSB-EP647008RMB
CSB-BP647008RMB
CSB-MP647008RMB
CSB-EP647008RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP647009RMB
CSB-EP647009RMB
CSB-BP647009RMB
CSB-MP647009RMB
CSB-EP647009RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum ATP synthase subunit beta (atpD) CSB-YP647010RMB
CSB-EP647010RMB
CSB-BP647010RMB
CSB-MP647010RMB
CSB-EP647010RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 3-isopropylmalate dehydrogenase (leuB) CSB-YP647011RMB
CSB-EP647011RMB
CSB-BP647011RMB
CSB-MP647011RMB
CSB-EP647011RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Potassium-transporting ATPase A chain (kdpA), partial CSB-YP647012RMB
CSB-EP647012RMB
CSB-BP647012RMB
CSB-MP647012RMB
CSB-EP647012RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Probable transcriptional regulatory protein Rru_A1086 (Rru_A1086) CSB-YP647013RMB
CSB-EP647013RMB
CSB-BP647013RMB
CSB-MP647013RMB
CSB-EP647013RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP647014RMB
CSB-EP647014RMB
CSB-BP647014RMB
CSB-MP647014RMB
CSB-EP647014RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>